1. Home
  2. WVE vs WB Comparison

WVE vs WB Comparison

Compare WVE & WB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$13.40

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Logo Weibo Corporation

WB

Weibo Corporation

HOLD

Current Price

$10.84

Market Cap

2.5B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
WVE
WB
Founded
2012
2009
Country
Singapore
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.5B
IPO Year
2015
2014

Fundamental Metrics

Financial Performance
Metric
WVE
WB
Price
$13.40
$10.84
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
16
1
Target Price
$29.94
$14.00
AVG Volume (30 Days)
4.0M
978.0K
Earning Date
03-03-2026
03-12-2026
Dividend Yield
N/A
15.06%
EPS Growth
N/A
20.16
EPS
N/A
1.76
Revenue
$109,230,000.00
$1,740,785,000.00
Revenue This Year
N/A
$0.53
Revenue Next Year
$16.20
$2.38
P/E Ratio
N/A
$6.20
Revenue Growth
103.75
N/A
52 Week Low
$5.28
$7.10
52 Week High
$21.73
$12.96

Technical Indicators

Market Signals
Indicator
WVE
WB
Relative Strength Index (RSI) 43.21 54.59
Support Level $13.22 $10.52
Resistance Level $14.51 $11.10
Average True Range (ATR) 1.33 0.27
MACD -0.38 0.01
Stochastic Oscillator 3.18 44.26

Price Performance

Historical Comparison
WVE
WB

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About WB Weibo Corporation

Weibo Corp is a China-based company mainly engaged in the social media advertising business for people to create, discover and distribute content. The company's activities include Advertising and Marketing, which mainly provides a full range of advertising customization and marketing solutions. The Value-added Services mainly provide services such as membership services on social platforms, online games, live broadcasts, social e-commerce, and others. The Company's main product is the social platform Weibo.

Share on Social Networks: